SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-22-040534
Filing Date
2022-11-08
Accepted
2022-11-08 17:17:41
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 ny20005640x1_s3.htm S-3 650425
2 EXHIBIT 1.2 ny20005640x1_ex1-2.htm EX-1.2 173762
3 EXHIBIT 4.4 ny20005640x1_ex4-4.htm EX-4.4 322391
4 EXHIBIT 4.5 ny20005640x1_ex4-5.htm EX-4.5 345994
5 EXHIBIT 5.1 ny20005640x1_ex5-1.htm EX-5.1 17913
6 EXHIBIT 5.2 ny20005640x1_ex5-2.htm EX-5.2 8648
7 EXHIBIT 23.1 ny20005640x1_ex23-1.htm EX-23.1 2075
8 FILING FEES TABLE ny20005640x1_ex107.htm EX-FILING FEES 165214
9 logo_avrobiox1.jpg GRAPHIC 40518
10 logo_avrobiox2.jpg GRAPHIC 49152
11 logo_avrobiox3.jpg GRAPHIC 42342
12 logo_avrobiox4.jpg GRAPHIC 45587
  Complete submission text file 0001140361-22-040534.txt   1931471
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268255 | Film No.: 221369958
SIC: 2836 Biological Products, (No Diagnostic Substances)